PHMY 771_ DRUG QUIZ 3 2/5/2026
apixaban (Eliquis) counseling points discontinue 24 hours before elective surgery with low bleed risk, or 48 hours before surgery
with moderate-high bleed risk
Apresoline hydralazine
Azor amlodipine/olmesartan
BBW of apixaban (Eliquis) patients getting neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
BBW of clopidogrel (Plavix) CYP2C19 poor metabolizers have had higher rate of CV events because clopidogrel must
be converted to an active metabolite by CYP2C19
BBW of dabigatran etexilate (Pradaxa) patients getting neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
PHMY 771_ DRUG QUIZ 3 Page 1 of 22
,PHMY 771_ DRUG QUIZ 3 2/5/2026
BBW of enoxaparin (Lovenox) patients getting neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
BBW of ticagrelor (Brilinta) significant bleeding
BBW of warfarin major/fatal bleeding
Brilinta ticagrelor
Calan, Calan SR verapamil
Cardizem (SR, CD, LA), Tiazac diltiazem
PHMY 771_ DRUG QUIZ 3 Page 2 of 22
, PHMY 771_ DRUG QUIZ 3 2/5/2026
common indication of apixaban (Eliquis) stroke prevention in Afib, VTE treatment, DVT prophylaxis after knee/hip replacement
common indication of nitroglycerin SL (Nitrostat) Angina
common indications of amlodipine (Norvasc) HTN
common indications of aspirin (Ecotrin) secondary stroke prevention, stable ischemic heart disease
common indications of clopidogrel (Plavix) secondary stroke prevention, stable ischemic heart disease
common indications of dabigatran extexilate (Pradaxa) stroke prevention in atrial fibrillation, VTE treatment
PHMY 771_ DRUG QUIZ 3 Page 3 of 22
apixaban (Eliquis) counseling points discontinue 24 hours before elective surgery with low bleed risk, or 48 hours before surgery
with moderate-high bleed risk
Apresoline hydralazine
Azor amlodipine/olmesartan
BBW of apixaban (Eliquis) patients getting neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
BBW of clopidogrel (Plavix) CYP2C19 poor metabolizers have had higher rate of CV events because clopidogrel must
be converted to an active metabolite by CYP2C19
BBW of dabigatran etexilate (Pradaxa) patients getting neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
PHMY 771_ DRUG QUIZ 3 Page 1 of 22
,PHMY 771_ DRUG QUIZ 3 2/5/2026
BBW of enoxaparin (Lovenox) patients getting neuraxial anesthesia or spinal puncture (risk of hematoma and paralysis)
BBW of ticagrelor (Brilinta) significant bleeding
BBW of warfarin major/fatal bleeding
Brilinta ticagrelor
Calan, Calan SR verapamil
Cardizem (SR, CD, LA), Tiazac diltiazem
PHMY 771_ DRUG QUIZ 3 Page 2 of 22
, PHMY 771_ DRUG QUIZ 3 2/5/2026
common indication of apixaban (Eliquis) stroke prevention in Afib, VTE treatment, DVT prophylaxis after knee/hip replacement
common indication of nitroglycerin SL (Nitrostat) Angina
common indications of amlodipine (Norvasc) HTN
common indications of aspirin (Ecotrin) secondary stroke prevention, stable ischemic heart disease
common indications of clopidogrel (Plavix) secondary stroke prevention, stable ischemic heart disease
common indications of dabigatran extexilate (Pradaxa) stroke prevention in atrial fibrillation, VTE treatment
PHMY 771_ DRUG QUIZ 3 Page 3 of 22
